![Carol Scambler](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Carol Scambler
Keine laufenden Positionen mehr
Karriereverlauf von Carol Scambler
Ehemalige bekannte Positionen von Carol Scambler
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
EnteroBiotix Ltd.
![]() EnteroBiotix Ltd. Medical SpecialtiesHealth Technology EnteroBiotix Ltd. develops novel microbiome modulating drugs which are composed of live microorganisms. It focuses on faecal microbiota transplantation which transfers bacteria from a healthy donor into a recipient having an infection caused by a bacterium called C.difficile. The company was founded by James Roger McIlroy in March 2017 and is headquartered in Aberdeen, the United Kingdom. | Direktor/Vorstandsmitglied | - | - |
Investor Relations Kontakt | - | - | |
INDIGOVISION GROUP PLC | Personalreferent | 06.10.2009 | - |
Statistik
International
Vereinigtes Königreich | 3 |
Operativ
Human Resources Officer | 1 |
Director/Board Member | 1 |
Investor Relations Contact | 1 |
Sektoral
Consumer Durables | 2 |
Health Technology | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 2 |
---|---|
IndigoVision Group Ltd.
![]() IndigoVision Group Ltd. Electronics/AppliancesConsumer Durables IndigoVision Group Plc engages in the development, manufacture, and sale of networked video security systems. It operates through the following geographical segments: Europe, Middle East, and Africa; North America; Latin America; and Asia Pacific. Its products include management software; artificial intelligence; management hardware; cameras and encoders; recorders; specialized cameras; body worn video; and integration. The company was founded by Oliver Richard Vellacott in 1994 and is headquartered in Edinburgh, the United Kingdom. | Consumer Durables |
EnteroBiotix Ltd.
![]() EnteroBiotix Ltd. Medical SpecialtiesHealth Technology EnteroBiotix Ltd. develops novel microbiome modulating drugs which are composed of live microorganisms. It focuses on faecal microbiota transplantation which transfers bacteria from a healthy donor into a recipient having an infection caused by a bacterium called C.difficile. The company was founded by James Roger McIlroy in March 2017 and is headquartered in Aberdeen, the United Kingdom. | Health Technology |
- Börse
- Insiders
- Carol Scambler
- Erfahrung